List of works - Marie-Claude Gaillard

Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin

scientific article

Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment

scientific article published on 11 July 2005

Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II.

scientific article published on 11 February 2008

Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactions

scientific article

Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models

scientific article published on 5 February 2008

Quantitative assessment of transcriptome differences between brain territories

scientific article

Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo

scientific article

Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease

scientific article published on 16 October 2018

SET translocation is associated with increase in caspase cleaved amyloid precursor protein in CA1 of Alzheimer and Down syndrome patients

scientific article published on 5 November 2013

Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease

scientific article

Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing

scientific article

IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primates

scientific article

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin.

scientific article published on 9 March 2018

Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo

scientific article published on 24 February 2012

The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo

scientific article published on 09 October 2019

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates

scientific article (publication date: 30 January 2013)

Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer's Disease

scientific article published on 01 March 2020

List of works by Marie-Claude Gaillard

Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin

Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment

Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II.

Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactions

Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models

Quantitative assessment of transcriptome differences between brain territories

Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo

Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease

SET translocation is associated with increase in caspase cleaved amyloid precursor protein in CA1 of Alzheimer and Down syndrome patients

Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease

Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing

IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primates

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin.

Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo

The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates

Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer's Disease